 - Time to ISS7 MID during the randomized-treatment epoch. Treatment comparisons of 300 mg vs placebo and 150 mg vs placebo will be performed using a Cox proportional hazard PH model with treatment group as a factor and baseline ISS7 as a covariate. Multiplicity adjustment will be made for testing the primary and secondary hypotheses according to the type I error control plan. 